Yahoo
OTC Markets OTCQX - Delayed Quote USD

Jushi Holdings Inc. (JUSHF)

0.5230 +0.0370 (+7.61%)
At close: May 28 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for JUSHF
  • Previous Close 0.4860
  • Open 0.4993
  • Bid 0.5102 x 100000
  • Ask 0.5203 x 500000
  • Day's Range 0.4911 - 0.5230
  • 52 Week Range 0.2650 - 0.9800
  • Volume 64,644
  • Avg. Volume 192,914
  • Market Cap (intraday) 104.441M
  • Beta (5Y Monthly) 0.90
  • PE Ratio (TTM) --
  • EPS (TTM) -0.3600
  • Earnings Date (est.) Aug 4, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 1.50

Jushi Holdings Inc. engages in the retail, distribution, cultivation, and processing of cannabis for medical and adult-use markets in the United States. The company offers flower, vapes, concentrates, infused chews and chocolates, tinctures, capsules, softgels, topicals and RSO, pre-rolls, and infused chocolate bites under the Hijinks, The Bank, The Lab, Tasteology, Uncommon Kind, Nira + Medicinals, Sèche, Shayo, and Carm's Delight Bites brands. It also engages in the sale of bulk raw materials to duly licensed third parties for use in its own finished products. In addition, the company operates medical cannabis dispensaries under the Beyond Hello, Nature's Remedy, and NuLeaf brands. It serves small local dispensaries and large multi-state operators. Jushi Holdings Inc. was founded in 2018 and is headquartered in Boca Raton, Florida.

jushico.com

1,288

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 5/28/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

JUSHF
15.92%
S&P/TSX Composite index (^GSPTSE)
8.32%

1-Year Return

JUSHF
72.04%
S&P/TSX Composite index (^GSPTSE)
31.33%

3-Year Return

JUSHF
11.28%
S&P/TSX Composite index (^GSPTSE)
73.28%

5-Year Return

JUSHF
91.01%
S&P/TSX Composite index (^GSPTSE)
73.87%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY25
Revenue 68.34M
Earnings -12.56M

Q1

FY25

Q2

FY25

Q3

FY25

Q4

FY25

0
20M
40M
60M

Analyst Insights

View More

Analyst Price Targets

1.00
1.50 Average
0.5230 Current
2.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 11/23/2022
Analyst Cantor Fitzgerald
Rating Action Maintains
Rating Neutral
Price Action Raises
Price Target 2.25 -> 2.35

Statistics

View More

Valuation Measures

Annual
As of 5/28/2026
  • Market Cap

    104.12M

  • Enterprise Value

    365.63M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.39

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    1.38

  • Enterprise Value/EBITDA

    10.20

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -26.90%

  • Return on Assets (ttm)

    1.20%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    265.5M

  • Net Income Avi to Common (ttm)

    -71.42M

  • Diluted EPS (ttm)

    -0.3600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    39.7M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -3.31M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: